HO161: HOVON 161: A phase II non-inferiority study comparing point-of-care produced CAR T-cell to commercial CAR T-cells in patients with relapsed/refractory Non-Hodgkin Lymphoma (clinicaltrialsregister.eu) - Sep 24, 2026 - P1/2 | N=340 | Active, not recruiting | Sponsor: Universitair Medisch Centrum Groningen | Recruiting ➔ Active, not recruiting
Enrollment closed • Head-to-Head • B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • BCL2 • BCL6
|